These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27389320)

  • 21. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
    Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
    Raynor MC; Carson CC; Pearson MD; Nix JW
    Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism.
    Okada K; Yamaguchi K; Chiba K; Miyake H; Fujisawa M
    Aging Male; 2014 Jun; 17(2):72-5. PubMed ID: 24533913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone for 'late-onset hypogonadism' in men?
    Drug Ther Bull; 2010 Jun; 48(6):69-72. PubMed ID: 20530029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone and men's quality of life.
    Moncada I
    Aging Male; 2006 Dec; 9(4):189-93. PubMed ID: 17178553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can testosterone level be a good predictor of late-onset hypogonadism?
    Heidari R; Sajadi H; Pourmand A; Pourmand G
    Andrologia; 2015 May; 47(4):433-7. PubMed ID: 24773173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan.
    Shigehara K; Konaka H; Koh E; Izumi K; Kitagawa Y; Mizokami A; Nakashima T; Shimamura M; Iwamoto T; Namiki M
    Aging Male; 2015; 18(3):169-74. PubMed ID: 26075538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset hypogonadism a challenging task for the andrology field.
    Corona G; Krausz C
    Andrology; 2020 Nov; 8(6):1504-1505. PubMed ID: 33460316
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Effects of Long-Term Androgen Replacement Therapy on the Physical and Mental Statuses of Aging Males with Late-Onset Hypogonadism: A Multicenter Randomized Controlled Trial in Japan (EARTH Study).
    Seftel AD
    J Urol; 2015 Sep; 194(3):760. PubMed ID: 26292882
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between the Japanese Aging Male Questionnaire (JAMQ) and Aging Male's Symptom (AMS) scale in Japanese male.
    Horie S; Hisasue S; Nakao M; Ide H; China T; Nagae M; Saito K; Isotani S; Yamaguchi R; Muto S; Kumamoto Y
    Aging Male; 2014 Mar; 17(1):35-41. PubMed ID: 24070116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients.
    Strollo F; Strollo G; Morè M; Magni P; Macchi C; Masini MA; Carucci I; Celotti F; Ruscica M; Gentile S
    Aging Male; 2013 Jun; 16(2):33-7. PubMed ID: 23517433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of short-acting testosterone ointment (Glowmin) for late-onset hypogonadism in accordance with testosterone circadian rhythm.
    Amano T; Iwamoto T; Sato Y; Imao T; Earle C
    Aging Male; 2018 Sep; 21(3):170-175. PubMed ID: 29734846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
    Permpongkosol S; Tantirangsee N; Ratana-olarn K
    J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.
    Shigehara K; Sugimoto K; Konaka H; Iijima M; Fukushima M; Maeda Y; Mizokami A; Koh E; Origasa H; Iwamoto T; Namiki M
    Aging Male; 2011 Mar; 14(1):53-8. PubMed ID: 21171937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
    Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
    Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related androgen deficiency and type 2 diabetes.
    Ryan GJ; Jobe LJ
    J Pharm Pract; 2011 Jun; 24(3):316-22. PubMed ID: 21676855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.